![]() ![]() Pulmonary artery pressure–guided management of patients with heart failure and reduced ejection fraction. Givertz MM, Stevenson LW, Costanzo MR, et al., on behalf of the CHAMPION Trial Investigators.Ambulatory hemodynamic monitoring reduces heart failure hospitalizations in “real-world” clinical practice. Desai AS, Bhimaraj A, Bharmi R, et al.Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF). Angermann, C.E., Assmus, B., Anker, S.D.Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Abraham WT, Stevenson LW, Bourge RC, Lindenfeld JA, Bauman JG, Adamson PB, for the CHAMPION Trial Study Group.Association of Ambulatory Hemodynamic Monitoring with Clinical Outcomes in a Concurrent Matched Cohort Analysis. We are a comprehensive subscription-based service provider and information. ![]() ![]() Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: new insights from continuous monitoring devices. MedAxiom is one of the most valuable resources a cardiology practice can have. ![]() Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Adamson PB, Abraham WT, Bourge RC, Costanzo MR, Hasan A, Yadav C, et al. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |